Neural stem cells in regenerative medicine: Bridging the gap

Panminerva Medica

Volumn 52, Issue 2, 2010, Pages 125-147

  Ruff, C A ^a,b   Fehlings, M G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Regenerative medicine; Spinal cord injuries; Stem cells

Indexed keywords

ANIMAL; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL; HUMAN; NERVE CELL; NERVE REGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIALS AS TOPIC; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NERVE REGENERATION; NEURONS; REGENERATIVE MEDICINE; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 77955457938     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (326)

1. Christopher and Dana Reeve Foundation. One Degree of Separation: Paralysis and Injury in the United States; 2010.
2. National Spinal Cord Injury Statistical Center. Spinal cord injury - facts and figures at a glance [Internet]. Birmingham, Alabama: National Spinal Cord Injury Statistical Center; 2009. Available from: www.uab.edu/NSCISC [cited April 30,2010].
3. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres. Philosophical Transactions of the Royal Society of London 1850;140:423-429
4. Nixon RA, Saito KI, Grynspan F, Griffin WR, Katayama S, Honda T etal. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann NY Acad Sci 1994;747:77-91.
5. Schlaepfer WW, Hasler MB. Characterization of the calcium-induced disruption of neurofilaments in rat peripheral nerve. Brain Res 1979;168:299-309.
6. Schumacher PA, Eubanks JH, Fehlings MG. Increased calpain I-mediated proteolysis, and preferential loss of dephosphorylated NF200, following traumatic spinal cord injury. Neuroscience 1999;91:733-744
7. Balentine JD. Spinal cord trauma: in search of the meaning of granular axoplasm and vesicular myelin. J Neuropathol Exp Neurol 1988;47:77-92.
8. Stokes BT, Fox P, Hollinden G. Extracellular calcium activity in the injured spinal cord. Exp Neurol 1983;80:561-572
9. Krause TL, Fishman HM, Ballinger ML, Bittner GD. Extent and mechanism of sealing in transected giant axons of squid and earthworms. J Neurosci 1994;14(11 Pt 1):6638-6651
10. Kerschensteiner M, Schwab ME, Lichtman JW, Misgeld T. in vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med 2005; 11:572-577
11. Rowland JW, Hawryluk GWJ, Kwon B, Fehlings MG. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 2008;25:E2.
12. Atkinson PP, Atkinson JL. Spinal shock. Mayo Clin Proc 1996;71:384-389
13. Ditunno JF, Little JW, Tessler A, Burns AS. Spinal shock revisited: a four-phase model. Spinal Cord 2004;42:383-395
14. Woodside JR, McGuire EJ. Urethral hypotonicity after suprasacral spinal cord injury. J Urol 1979;121:783-785
15. Little JW, Ditunno JF, Stiens SA, Harris RM. Incomplete spinal cord injury: neuronal mechanisms of motor recovery and hyperreflexia. Arch Phys Med Rehabil 1999;80:587-599
16. Fehlings MG, Tator CH. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol 1995;132:220-228
17. Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 2009;6:e 1000113.
18. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004;5:146-156
19. Melli G, Höke A. Canadian Association of Neurosciences review: regulation of myelination by trophic factors and neuron-glial signaling. Can J Neurol Sci 2007;34:288-295
20. Trapp BD, Hauer P, Lemke G. Axonal regulation of myelin protein mRNA levels in actively myelinating Schwann cells. J Neurosci 1988;8:3515-3521
21. White FV, Toews AD, Goodrum JF, Novicki DL, Bouldin TW, Morell P et al. Lipid metabolism during early stages of Wallerian degeneration in the rat sciatic nerve. J Neurochem 1989;52:1085-1092
22. Morrison S, Mitchell LS, Ecob-Prince MS, Griffiths IR, Thomson CE, Barrie JA et al. P0 gene expression in cultured Schwann cells. J Neurocytol 1991;20:769-780
23. Filbin MT. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 2003;4:703-713
24. Schwab ME. Nogo and axon regeneration. Curr Opin Neurobiol 2004;14:118-124
25. Spencer T FM. A role for cAMP in regeneration of the adult mammalian CNS. J Anat 2004;204:49-55.
26. Giger RJ, Venkatesh K, Chivatakarn O, Raiker SJ, Robak L, Hofer T et al. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems. Restor Neurol Neurosci. 2008;26:97-115.
27. Goodman JH, Bingham WG, Hunt WE. Platelet aggregation in experimental spinal cord injury. Ultrastructural observations. Arch Neurol 1979;36:197-201.
28. Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008;209:378-388
29. Aloisi F. Immune function of microglia. Glia 2001 ;36:165-179
30. Davies AL, Hayes KC, Dekaban GA. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch Phys Med Rehabil 2007;88:1384-1393
31. Sanders VM, Jones KJ. Role of immunity in recovery from a peripheral nerve injury. J Neuroimmune Pharmacol 2006; 1:11-19
32. Matsumoto Y, Hara N, Tanaka R, Fujiwara M. Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to la-positive cells with dendritic morphology. J Immunol 1986;136:3668-3676
33. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG. Microglia in degenerative neurological disease. Glia 1993;7:84-92.
34. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988;239:290-292
35. Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 2002;202:13-23.
36. Woodroofe MN, Sarna GS, Wadhwa M, Hayes GM, Loughlin AJ, Tinker A et al. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol 1991;33:227-236
37. Makwana M, Werner A, Acosta-Saltos A, Gonitel R, Pararajasingham A, Ruff C et al. Peripheral facial nerve axotomy in mice causes sprouting of motor axons into perineuronal central white matter: Time course and molecular characterization. J Comp Neurol. 2009;518:699-721.
38. Dopp JM, Mackenzie-Graham A, Otero GC, Merrill JE. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol 1997;75:104-112
39. Woo M, Jang P, Park J, Kim WK, Joh TH, Kim HS. Selective modulation of lipopolysaccharide-stimulated cytokine expression and mito-gen-activated protein kinase pathways by dibutyryl-cAMP in BV2 microglial cells. Brain Res Mol Brain Res 2003;113:86-96.
40. Kraft AD, McPherson CA, Harry GJ. Heterogeneity of microglia and TNF signaling as determinants for neuronal death or survival. NeuroToxicology 2009;30:785-793
41. Jana M, Dasgupta S, Liu X, Pahan K. Interleukin-12 P40 induces the expression of TNF-;l; in microglia and macrophages. J Neurochem 2002;81(s1):52-53
42. Babcock AA, Kuziel WA, Rivest S, Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 2003;23:7922-7930
43. Pineau I, Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved. J Compar Neurol 2007;500:267-285
44. Franklin RJM, ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008;9:839-855
45. Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, Pluchino S et al. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 2006;31:149-160
46. Qin H, Roberts KL, Niyongere SA, Cong Y, Elson CO, Benveniste EN. Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia. J Immunol 2007; 179:5966-5976
47. Suh H, Kim M, Lee SC. Inhibition of Granulocyte-Macrophage Colony-Stimulating Factor Signaling and Microglial Proliferation by Anti-CD45RO: Role of Hck Tyrosine Kinase and Phosphatidylinositol 3-Kinase/Akt. J Immunol 2005;174:2712-2719
48. Bohatschek M, Kloss CU, Pfeffer K, Bluethmann H, Raivich G. B7.2 on activated and phagocytic microglia in the facial axotomy model: regulation by interleukin-1 receptor type 1, tumor necrosis factor receptors 1 and 2 and endotoxin. J Neuroimmunol 2004;156:132-145
49. Bohatschek M, Kloss CU, Kalla R, Raivich G. In vitro model of microglial deramification: ramified microglia transform into amoeboid phagocytes following addition of brain cell membranes to microglia-astrocyte cocultures. J Neurosci Res 2001 ;64:508-522
50. Hristova M, Cuthill D, Zbarsky V, Acosta-Saltos A, Wallace A, Blight K et al. Activation and deactivation of periventricular white matter phagocytes during postnatal mouse development. Glia. 2009. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=19544386.
51. Priller J, Fliigel A, Wehner T, Boentert M, Haas CA, Prinz M et al. Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat Med 2001 ;7:1356-1361
52. Flügel A, Bradl M, Kreutzberg GW, Graeber MB. Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy. J Neurosci Res 2001 ;66:74-82.
53. DiPietro LA, Burdick M, Low QE, Kunkel SL, Strieter RM. MIP-1 alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest 1998;101:1693-1698
54. Gallin JI, Goldstein IM. Inflammation: Basic Principles and Clinical Correlates. 2nd ed. Lippincott Williams & Wilkins; 1992.
55. North RJ. The concept of the activated macrophage. J Immunol 1978;121:806-809
56. Murray HW. Interferon-Gamma, the Activated Macrophage, and Host Defense Against Microbial Challenge. Ann Int Med 1988; 108:595-608.
57. Goerdt S, Orfanos CE. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999; 10:137-142
58. Lindholm D, Heumann R, Meyer M, Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987;330:658-659 (Pubitemid 18005581)
59. Nathan DG, Sieff CA. The biological activities and uses of recombinant granulocyte-macrophage and multi-colony stimulating factors. Prog Hematol 1987;15:1-18.
60. Stolz B, Erulkar SD, Kuffler DP. Macrophages direct process elongation from adult frog motorneurons in culture. Proc Biol Sci 1991;244:227-231
61. Miyauchi A, Kanje M, Danielsen N, Dahlin LB. Role of macrophages in the stimulation and regeneration of sensory nerves by transposed granulation tissue and temporal aspects of the response. Scand J Plast Reconstr Surg Hand Surg 1997;31:17-23.
62. Lu X, Richardson PM. Inflammation near the nerve cell body enhances axonal regeneration. J Neurosci 1991; 11:972-978
63. Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007;28:138-145.
64. Bramanti V, Tomassoni D, Avitabile M, Amenta F, Avola R. Biomarkers of glial cell proliferation and differentiation in culture. Front Biosci (Schol Ed) 2010;2:558-570
65. Tichauer J, Saud K, von Bernhardi R. Modulation by astrocytes of microglial cell-mediated neuroinflammation: effect on the activation of microglial signaling pathways. Neuroimmunomodulation 2007;14:168-174
66. Ranaivo HR, Wainwright MS. Albumin activates astrocytes and microglia through mitogen-activated protein kinase pathways [Internet]. Brain Res. 2009. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/19961838 [cited 2009, Dec 30].
67. Genovese T, Cuzzocrea S. Role of free radicals and poly(ADP-ribose) polymerase-l in the development of spinal cord injury: new potential therapeutic targets. Curr Med Chem 2008;15:477-487
68. Ronaghi M, Erceg S, Moreno-Manzano V, Stojkovic M. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells 2010;28:93-99
69. Casha S, Yu WR, Fehlings MG. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 2001;103:203-218
70. Sesaki H, Jensen RE. UGOl encodes an outer membrane protein required for mitochondrial fusion. J Cell Biol 2001; 152:1123-1134
71. Demestre M, Wells GM, Miller KM, Smith KJ, Hughes RA, Gearing AJ et al. Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration. Neuroscience 2004;124:767-779
72. Davies JE, Tang X, Bournat JC, Davies SJ. Decorin promotes plas-minogen/plasmin expression within acute spinal cord injuries and by adult microglia in vitro. J Neurotrauma 2006;23:397-408.
73. Rolls A, Shechter R, London A, Segev Y, Jacob-Hirsch J, Amariglio N et al. Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med 2008;5:el71.
74. Asher RA, Morgenstern DA, Fidler PS, Adcock KH, Oohira A, Braistead JE et al. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci 2000;20:2427-2438
75. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002;416:636-640
76. Properzi F, Asher RA, Fawcett JW. Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury. Biochem Soc Trans 2003;31:335-336
77. Sandvig A, Berry M, Barrett LB, Butt A, Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 2004;46:225-251
78. Beggah AT, Dours-Zimmermann MT, Barras FM, Brosius A, Zimmermann DR, Zurn AD. Lesion-induced differential expression and cell association of Neurocan, Brevican, Versican V1 and V2 in the mouse dorsal root entry zone. Neuroscience 2005;133:749-762
79. Buss A, Pech K, Kakulas BA, Martin D, Schoenen J, Noth J et al. NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury. BMC Neurol 2009;9:32.
80. Tick LW, Cheung PT, So KF, Wu W. Axonal regeneration of Clarke's neurons beyond the spinal cord injury scar after treatment with chondroitinase ABC. Exp Neurol 2003; 182:160-168
81. Ikegami T, Nakamura M, Yamane J, Katoh H, Okada S, Iwanami A et al. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur J Neurosci 2005;22:3036-3046
82. Curinga GM, Snow DM, Mashburn C, Kohler K, Thobaben R, Caggiano AO et al. Mammalian-produced chondroitinase AC mitigates axon inhibition by chondroitin sulfate proteoglycans. J Neurochem 2007;102:275-288
83. Tom VJ, Houle JD. Intraspinal microinjection of chondroitinase ABC following injury promotes axonal regeneration out of a peripheral nerve graft bridge. Exp Neurol 2008;211:315-319
84. Nakamae T, Tanaka N, Nakanishi K, Kamei N, Sasaki H, Hamasaki T et al. Chondroitinase ABC promotes corticospinal axon growth in organotypic cocultures. Spinal Cord 2009;47:161-165
85. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Schut D, Fehlings MG. Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci 2010;30:1657-1676
86. Tom VJ, Sandrow-Feinberg HR, Miller K, Santi L, Connors T, Lemay MA et al. Combining peripheral nerve grafts and chondroitinase promotes functional axonal regeneration in the chronically injured spinal cord. J Neurosci 2009;29:14881-14890
87. Fouad K, Pearse DD, Tetzlaff W, Vavrek R. Transplantation and repair: combined cell implantation and chondroitinase delivery prevents deterioration of bladder function in rats with complete spinal cord injury. Spinal Cord 2009;47:727-732
88. Groves M, McKeon R, Werner E, Nagarsheth M, Meador W, English AW. Axon regeneration in peripheral nerves is enhanced by proteoglycan degradation. Experiment Neurol 2005;195:278-292
89. Garcia-Alias G, Barkhuysen S, Buckle M, Fawcett JW. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat Neurosci 2009; 12:1145-1151
90. Galtrey CM, Asher RA, Nothias F, Fawcett JW. Promoting plasticity in the spinal cord with chondroitinase improves functional recovery after peripheral nerve repair. Brain 2007; 130:926-939
91. Shen Y, Tenney AP, Busch SA, Horn KP, Cuascut FX, Liu K et al. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009;326:592-596
92. Nikulina E, Tidwell JL, Dai HN, Bregman BS, Filbin MT. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc Natl Acad Sci U S A 2004; 101:8786-8790
93. Pearse DD, Pereira FC, Marcillo AE, Bates ML, Berrocal YA, Filbin MT et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med 2004; 10:610-616
94. Tian D, Yu Z, Xie M, Bu BT, Witte OW, Wang W. Suppression of ' astroglial scar formation and enhanced axonal regeneration associated with functional recovery in a spinal cord injury rat model by the cell cycle inhibitor olomoucine. J Neurosci Res 2006;84:1053-63.
95. Perrouin-Verbe B, Lenne-Aurier K, Robert R, Auffray-Calvier E, Richard I, Mauduyt de la Grève I et al. Post-traumatic syringomyelia and post-traumatic spinal canal stenosis: A direct relationship: Review of 75 patients with a spinal cord injury. Spinal Cord. 1998;36:137-143
96. Perrouin-Verbe B, Robert R, Lefort M, Auffray-Calvier E, Richard I, Mauduyt de la Grève I et al. Post-traumatic syringomyelia. Neurochirurgie 1999;45(SUPPL. 1):58-66.
97. Milhorat T, Capocelli Jr. A, Anzil A, Kotzen R, Milhorat R. Pathological basis of spinal cord cavitation in syringomyelia: Analysis of 105 autopsy cases. J Neurosurg 1995;82:802-812
98. Backe H, Betz R, Mesgarzadeh M, Beck T, Clancy M. Post-traumatic spinal cord cysts evaluated by magnetic resonance imaging. Paraplegia 1991;29:607-612
99. Rossier A, Foo D, Shillito J, Dyro F. Posttraumatic cervical syringomyelia. Incidence, clinical presentation, electrophysiological studies, syrinx protein and results of conservative and operative treatment. Brain 1985;108:439-461
100. Schurch B, Wichmann W, Rossier A. Post-traumatic syringomyelia (cystic myelopathy): A prospective study of449 patients with spinal cord injury. J Neurol Neurosurg Psych 1996;60:61-67 (Pubitemid 26012268)
101. Milhorat TH. Classification of syringomyelia. Neurosurgical FOCUS 2000;8:1-6.
102. Edgar R, Quail P. Progressive post-traumatic cystic and non-cystic myelopathy. Br J Neurosurg 1994;8:7-22.
103. Foo D, Bignami A, Rossier A. A case of post-traumatic syringomyelia. Neuropathological findings after 1 year of cystic drainage. Paraplegia 1989;27:63-69
104. Durward Q, Rice G, Ball M. Selective spinal cordectomy: Clinicopathological correlation. J Neurosurg 1982;56:359-367
105. El Masry W, Biyani A. Incidence, management, and outcome of post-traumatic syringomyelia: In memory of Mr Bernard Williams. J Neurol Neurosurg Psych 1996;60:141-146
106. Klekamp J, Batzdorf U, Samii M, Werner Bothe H. Treatment of syringomyelia associated with arachnoid scarring caused by arachnoiditis or trauma. J Neurosurg 1997;86:233-240
107. Klekamp J. The pathophysiology of syringomyelia - historical overview and current concept. Acta Neurochir (Wien) 2002; 144:649-664
108. Tator C, Fehlings M. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991;75:15-26.
109. Guizar-Sahagun G, Grijalva I, Madrazo I, Franco-Bourland R, Salgado H, Ibarra A et al. Development of post-traumatic cysts in the spinal cord of rats subjected to severe spinal cord contusion. Surg Neurol 1994;41:241-249
110. Fischbein N, Dillon W, Cobbs C, Weinstein P. The 'presyrinx' state: A reversible myelopathic condition that may precede syringomyelia. Am J Neuroradiol 1999;20:7-20.
111. Kakulas B. A review of the neuropathology of human spinal cord injury with emphasis on special features. J Spinal Cord Med 1999;22:119-124
112. Levy L. Toward an understanding of syringomyelia: MR imaging of CSF flow and neuraxis motion. Am J Neuroradiol 2000;21:45-46.
113. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Morshead CM, Fehlings MG. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci 2006;26:3377-3389
114. Bunge RP, Puckett WR, Becerra JL, Marcillo A, Quencer RM. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol 1993;59:75-89.
115. McDonald JW, Belegu V. Demyelination and remyelination after spinal cord injury. J Neurotrauma 2006;23:345-359
116. Nashmi R, Fehlings MG. Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord. Neuroscience 2001;104:235-251
117. Radojicic M, Reier PJ, Steward O, Keirstead HS. Septations in chronic spinal cord injury cavities contain axons. Exp Neurol 2005;196:339-341
118. Totoiu MO, Keirstead HS. Spinal cord injury is accompanied by chronic progressive demyelination. J Comp Neurol 2005;486:373-383
119. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005;25:4694-4705
120. Li S, Stys PK. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J Neurosci 2000;20:1190-1198
121. Li GL, Brodin G, Farooque M, Funa K, Holtz A, Wang WL et al. Apoptosis and expression of Bcl-2 after compression trauma to rat spinal cord. J Neuropathol Exp Neurol 1996;55:280-289
122. Liu XZ, Xu XM, Hu R, Du C, Zhang SX, McDonald JW et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 1997;17:5395-5406
123. Casha S, Yu W, Fehlings M. FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. Experiment Neurol 2005;196:390-400.
124. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-1456
125. Kakulas BA. Neuropathology: the foundation for new treatments in spinal cord injury. Spinal Cord 2004;42:549-563
126. Liu L, Lioudyno M, Tao R, Eriksson P, Svensson M, Aldskogius H. Hereditary absence of complement C5 in adult mice influences wal-lerian degeneration, but not retrograde responses, following injury to peripheral nerve. J Peripher Nerv Syst 1999;4:123-133
127. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 1997;3:73-76
128. Emery E, Aldana P, Bunge MB, Puckett W, Srinivasan A, Keane RW et al. Apoptosis after traumatic human spinal cord injury. J. Neurosurg 1998;89:911-920
129. Salewski RPF, Eftekharpour E, Fehlings MG. Are induced pluripo-tent stem cells the future of cell-based regenerative therapies for spinal cord injury? J Cell Physiol 2010;222:515-521
130. Tator CH, Koyanagi I. Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg 1997;86:483-492
131. Sokolova E, Reiser G. Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases. Thromb Haemost 2008;100:576-581
132. Fehlings MG, Tator CH, Linden RD. The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroencephalogr Clin Neurophysiol 1989;74:241-259
133. Lee G, Kim H, ElkabetzY, Al Shamy G, Panagiotakos G, Barberi T et al. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol 2007;25:1468-1475
134. Gil J, Woo D, Shim J, Kim SE, You HJ, Park SH et al. Vitronectin promotes oligodendrocyte differentiation during neurogenesis of human embryonic stem cells. FEBS Lett 2009;583:561-567
135. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676
136. Wernig M, Zhao J, Pruszak J, Hedlund E, Fu D, Soldner F et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 2008;105:5856-5861
137. Ibrahim AG, Kirkwood PA, Raisman G, Li Y. Restoration of hand function in a rat model of repair of brachial plexus injury. Brain 2009;132(Pt 5): 1268-1276
138. Biemaskie J, Sparling JS, Liu J, Shannon CP, Plemel JR, Xie Y et al. Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J Neurosci 2007;27:9545-9559
139. Jiang S, Khan MI, Wang J, Middlemiss PJ, Werstiuk ES, Wickson R et al. Enteric glia promote functional recovery of CTM reflex after dorsal root transection. Neuroreport 2003; 14:1301-1304
140. Weiss S, Dunne C, Hewson J, Wohl C, Wheatley M, Peterson AC et al. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci 1996;16:7599-7609
141. Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J et al. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 2000;20:2218-2228
142. Morshead CM, Reynolds BA, Craig CG, McBurney MW, Staines WA, Morassutti D et al. Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron 1994;13:1071-1082
143. Hawryluk GWJ, Fehlings MG. The center of the spinal cord may be central to its repair. Cell Stem Cell 2008;3:230-232
144. Meletis K, Barnabé-Heider F, Carlén M, Evergren E, Tomilin N, Shupliakov O et al. Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol 2008;6:el82.
145. Zhang S, Ge B, Duncan I. Tracing human oligodendroglial development in vitro. J Neurosci Res 2000;59:421-429
146. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisén J. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 1999;96:25-34.
147. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992;255:1707-1710
148. Temple S, Alvarez-Buylla A. Stem cells in the adult mammalian central nervous system. Curr Opin Neurobiol 1999;9:135-141
149. Cummings BJ, Uchida N, Tamaki SJ, Salazar DL, Hooshmand M, Summers R et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci USA 2005;102:14069-14074
150. Goldman SA, Schanz S, Windrem MS. Stem cell-based strategies for treating pediatric disorders of myelin. Hum Mol Genet 2008;17(R1):R76-83.
151. Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, Greenberg N et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 2006;9:268-275
152. Eftekharpour E, Karimi-Abdolrezaee S, Wang J, El Beheiry H, Morshead C, Fehlings MG. Myelination of congenitally dysmyeli-nated spinal cord axons by adult neural precursor cells results in formation of nodes of Ranvier and improved axonal conduction. J Neurosci 2007;27:3416-3428
153. Bottai D, Fiocco R, Gelain F, Defilippis L, Galli R, Gritti A et al. Neural Stem Cells in the Adult Nervous System. J Hematother Stem Cell Res 2003;12:655-670
154. Caldwell M, He X, Wilkie N, Pollack S, Marshall G, Wafford KA et al. Growth factors regulate the survival and fate of cells derived from human neurospheres. Nature Biotechnology 2001;19:475-479
155. Doetsch F, Caille I, Lim D, Garcia-Verdugo J, Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999;97:703-716
156. Nunes M, Roy N, Keyoung H, Goodman RR, McKhann G 2nd, Jiang L et al. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med 2003;9:439-447
157. Shetty AK, Zaman V, Turner DA. Pattern of long-distance projections from fetal hippocampal field CA3 and CA1 cell grafts in lesioned CA3 of adult hippocampus follows intrinsic character of respective donor cells. Neuroscience 2000;99:243-255
158. Parr AM, Tator CH, Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 2007;40:609-619
159. Hofstetter CP, Holmstrom NAV, Lilja JA, Schweinhardt P, Hao J, Spenger C et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 2005;8:346-353
160. Pfeifer K, Vroemen M, Caioni M, Aigner L, Bogdahn U, Weidner N. Autologous adult rodent neural progenitor cell transplantation represents a feasible strategy to promote structural repair in the chronically injured spinal cord. Regen Med 2006; 1:255-266
161. Cao Q, Howard RM, Dennison JB, Whittemore SR. Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Exp. Neurol 2002;177:349-359
162. Barnabé-Heider F, Friseń J. Stem cells for spinal cord repair. Cell Stem Cell 2008;3:16-24.
163. Kitada M, Chakrabortty S, Matsumoto N, Taketomi M, Ide C. Differentiation of choroid plexus ependymal cells into astrocytes after grafting into the pre-lesioned spinal cord in mice. Glia 2001;36:364-374 (Pubitemid 34010064)
164. Yang H, Lu P, McKay HM, Keirstead H, Steward O, Gage FH et al. Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury. J Neurosci 2006;26:2157-2166
165. Lee D, Oh Y, Jin B. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: Dual roles of mitogen-activated protein kinase signaling pathways. GLIA 2005;51:98-110.
166. Jessberger S, Toni N, Clemenson GD, Ray J, Gage FH. Directed differentiation of hippocampal stem/progenitor cells in the adult brain. Nat Neurosci 2008; 11:888-893
167. Tebar LA, Géranton SM, Parsons-Perez C, Fisher AS, Bayne R, Smith AJ et al. Deletion of the mouse Reglllbeta (Reg2) gene disrupts ciliary neurotrophic factor signaling and delays myelination of mouse cranial motor neurons. Proc Natl Acad Sci USA. 2008;105:11400-11405
168. Cao Q, He Q, Wang Y, Cheng X, Howard RM, Zhang Y et al. Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinalcord injury. J Neurosci 2010;30:2989-3001.
169. Cao Q, Xu X, Devries WH, Enzmann GU, Ping P, Tsoulfas P et al. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 2005;25:6947-6957
170. Kusano K, Enomoto M, Hirai T, Tsoulfas P, Sotome S, Shinomiya K et al Transplanted neural progenitor cells expressing mutant NT3 promote myelination and partial hindlimb recovery in the chronic phase after spinal cord injury. Biochem Biophys Res Commun 2010;393:812-817
171. Hooshmand MJ, Sontag CJ, Uchida N, Tamaki S, Anderson AJ, Cummings BJ. Analysis of host-mediated repair mechanisms after human CNS-stem cell
172. Babu H, Cheung G, Kettenmann H, Palmer TD, Kempermann G. Enriched monolayer precursor cell cultures from micro-dissected adult mouse dentate gyrus yield functional granule cell-like neurons. PLoS ONE 2007;2:e388.
173. Pollard SM, Conti L, Sun Y, Goffredo D, Smith A. Adherent neural stem (NS) cells from fetal and adult forebrain. Cereb Cortex 2006; 16 Suppl l:i 112-120.
174. Coutts M, Keirstead HS. Stem cells for the treatment of spinal cord injury. Exp Neurol 2008;209:368-377
175. Lladó J, Haenggeli C, Maragakis NJ, Snyder EY, Rothstein JD. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci 2004;27:322-331
176. Jensen JB, Parmar M. Strengths and limitations of the neurosphere culture system. Mol Neurobiol 2006;34:153-161
177. Moreno-Manzano V, Rodríguez-Jiménez FJ, García-Roselló M et al. Activated spinal cord ependymal stem cells rescue neurological function. Stem Cells 2009;27:733-743
178. Mitchell BD, Emsley JG, Magavi SSP, Arlotta P, Macklis JD. Constitutive and induced neurogenesis in the adult mammalian brain: manipulation of endogenous precursors toward CNS repair. Dev Neurosci 2004;26:101-117
179. Bambakidis N, Wang R, Franic L, Miller R. Sonic hedgehog-induced neural precursor proliferation after adult rodent spinal cord injury. J Neurosurg 2003 ;99(1 SUPPL.):70-75
180. Evans MJ, Kaufman MH. Establishment in culture of pluripoten-tial cells from mouse embryos. Nature 1981;292:154-156
181. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981 ;78:7634-7638
182. Thomson JA, Marshall VS. Primate embryonic stem cells. Curr Top Dev Biol 1998;38:133-165
183. Thomson JA, Itskovitz-Eldor J, Shapiro SS; Waknitz MA, Swiergiel JJ, Marshall VS et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-1147
184. Ko J, Park C, Koh H, Cho YH, Kyhm JH, Kim YS et al. Human embryonic stem cell-derived neural precursors as a continuous, stable, and on-demand source for human dopamine neurons. J Neurochem 2007;103:1417-1429
185. Richards M, Fong C, Chan W, Wong P, Bongso A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 2002;20:933-936
186. Lee H, Shamy GA, Elkabetz Y, Schofield CM, Harrsion NL, Panagiotakos G et al. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 2007;25:1931-1939 (Pubitemid 47258171)
187. Erceg S, Ronaghi M, Stojkovic M. Human embryonic stem cell differentiation toward regional specific neural precursors. Stem Cells 2009;27:78-87.
188. Bain G, Kitchens D, Yao M, Huettner J, Gottlieb D. Embryonic stem cells express neuronal properties in vitro. Develop Biol 1995;168:342-357
189. Nishimura F, Yoshikawa M, Kanda S, Nonaka M, Yokota H, Shiroi A et al. Potential use of embryonic stem cells for the treatment of mouse Parkinsonian models: Improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells 2003;21:171-180
190. Liu S, Qu Y, Stewart T, Howard MJ, Chakrabortty S, Holekamp TF et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A 2000;97:6126-6131
191. Briistle O, Jones K, Learish R, Karram K, Choudhary K, Wiestler OD et al. Embryonic stem cell-derived glial precursors: A source of myelinating transplants. Science 1999;285:754-756
192. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009;27:275-280
193. Wada T, Honda M, Minami I, Tooi N, Amagai Y, Nakatsuji N et al. Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. PLoS ONE 2009;4:e6722.
194. Wichterle H, Lieberam I, Porter JA, Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002;110:385-397
195. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, Topf N et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 2004;101:12543-12548
196. Yan Y, Yang D, Zarnowska ED, Du Z, Werbel B, Valliere C et al. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 2005;23:781-790
197. Shintani A, Nakao N, Kakishita K, Itakura T. Generation of dopamine neurons from embryonic stem cells in the presence of the neuraliz-ing activity of bone marrow stromal cells derived from adult mice. J Neurosci Res 2008;86:2829-2838
198. Friling S, Andersson E, Thömpson LH, Jonsson ME, Hebsgaard JB, Nanou E et al. Efficient production of mesencephalic dopamine neurons by Lmxla expression in embryonic stem cells. Proc Natl Acad Sci USA 2009;106:7613-7618
199. Cai J, Donaldson A, Yang M, German MS, Enikolopov G, Iacovitti L. The role of Lmx la in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model. Stem Cells 20O9;27:220-9.
200. Zhao Y, Xiao Z, Gao Y, Chen B, Zhao Y, Zhang J et al. Insulin rescues ES cell-derived neural progenitor cells from apoptosis by differential regulation of Akt and ERK pathways. Neurosci Lett 2007;429:49-54.
201. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448:318-324 (Pubitemid 47080337)
202. Pucéat M, Ballis A. Embryonic stem cells: from bench to bedside. Clin Pharmacol Ther 2007;82:337-339
203. McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 1999;5:1410-1412
204. Iwanami A, Kaneko S, Nakamura M, Kanemura Y, Mori H, Kobayashi S et al. Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res 2005;80:182-190 (Pubitemid 40676302)
205. Roy N, Nakano T, Keyoung H, Windrem M, Rashbaum WK, Alonso ML et al. Telomerase immortalization of neuronally restricted progenitor cells derived from the human fetal spinal cord. Nature Biotechnology 2004;22:297-305.
206. Kawai H, YamashitaT, OhtaY, Deguchi K, Nagotani S, Zhang X et al. Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J Cereb Blood Flow Metab 2010. [Epub ahead of print].
207. Rang S, Cho MS, Seo H, Yoon CJ, Oh SK, Choi YM et al. Efficient induction of oligodendrocytes from human embryonic stem cells. Stem Cells 2007;25:419-424
208. Neri M, Maderna C, Ferrari D, Cavazzin C, Vescovi AL, Gritti A. Robust Generation of Oligodendrocyte Progenitors from Human Neural Stem Cells and Engraftment in Experimental Demyelination Models in Mice. PLoS ONE 2010;5:el0145.
209. Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 2005;49:385-396
210. Sharp J, Keirstead HS. Stem cell-based cell replacement strategies for the central nervous system. Neurosci Lett 2009;456:107-111
211. Yang D, Zhang Z, Oldenburg M, Ayala M, Zhang S. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 2008;26:55-63.
212. Drukker M, Katchman H, Katz G, Even-Tov Friedman S, Shezen E, Hornstein E et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006;24:221-229
213. Li L, Baroja M, Majumdar A, Chadwick K, Rouleau A, Gallacher L et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004;22:448-456
214. Grinnemo K, Kumagai-Braesch M, Mansson-Broberg A, Skottman H, Hao X, Siddiqui A et al. Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online 2006;13:712-724
215. Preynat-Seauve O, de Rham C, Tirefort D, Ferrari-Lacraz S, Krause KH, Villard J et al. Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells. J Cell Mol Med 2009;13(9B):3556-3569
216. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007;1:55-70.
217. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 2007;25:1177-1181
218. Okita K, IchisakaT.Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317
219. Amabile G, Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med 2009;15:59-68.
220. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009;5:111-123
221. Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 2009;27:743-745
222. Wernig M, Meissner A, Cassady JP, Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008;2:10-12
223. Chang M, Kim D, Kim C, Kang HC, Yang E, Moon JI et al. Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells. PLoS ONE 2010;5:e9838.
224. Liu H, Zhu F, Yong J, Zhang P, Hou P, Li H et al. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 2008;3:587-590
225. Ebert AD, Yu J, Rose FF, Mattis VB, Lorson CL, Thomson JA et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009;457:277-280
226. Dimos JT, Rodoifa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W et al Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008;321:1218-1221
227. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009;136:964-977
228. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, Fasano CA et al. Modelling pathogenesis and treatment of familial dysau-tonomia using patient-specific iPSCs. Nature 2009;461:402-406
229. Kang L, Wang J, Zhang Y, Kou Z, Gao S. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 2009;5:135-138
230. Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, Martin G et al. Adult mice generated from induced pluripotent stem cells. Nature 2009;461:91-94
231. Zhao X, Li W, Lv Z, Zeng F, Zhou Q. iPS cells produce viable mice through tetraploid complementation. Nature 2009;461:86-90.
232. Maherali N, Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 2008;3:595-605.
233. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872
234. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008;454:49-55.
235. Silva J, Smith A. Capturing pluripotency. Cell 2008; 132:532-536
236. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen Retal. piggyBactransposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009;458:766-770
237. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009;458:771-775
238. Sommer CA, Stadtfeld M, Murphy GJ, Hochedlinger K, Kotton DN, Mostoslavsky G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009;27:543-549
239. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324:797-801.
240. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE et al Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008;26:795-797
241. Cho H, Lee C, Kwon Y, Paek JS, Lee SH, Hur J et al. Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 2010 May 3. [Epub ahead of print].
242. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009;4(5):381-384.
243. Kim JB, Sebastiano V, Wu G, Kim JB, Bravo MJ, Sasse P et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009;136:411-419
244. Sommer CA, Sommer AG, Longmire TA, Christodoulou C, Thomas DD, Gostissa M et al. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 2010;28:64-74.
245. Yu J, Vodyanik M, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920
246. Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY, Blau HM. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010;463:1042-1047
247. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008;26: 101-106
248. Shi Y, Desponts C, Do JT, Hahm HS, Schöler HR, Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008;3:568-574
249. Shi Y, Do JT, Desponts C, Hahm HS, Schöler HR, Ding S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008;2:525-528
250. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008;26:1269-1275
251. Kubicek S, O'Sullivan RJ, August EM, Hickey ER, Zhang Q, Teodoro ML et al. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell 2007;25:473-481
252. Lyssiotis CA, Foreman RK, Staerk J, Garcia M, Mathur D, Markoulaki S etal. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci USA 2009;106:8912-8917
253. Ichida JK, Blanchard J, Lam K, Son EY, Chung JE, Egli D et al. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 2009;5:491-503.
254. Akamatsu W, DeVeale B, Okano H, Cooney AJ, van der Kooy D. Suppression of Oct4 by germ cell nuclear factor restricts pluripotency and promotes neural stem cell development in the early neural lineage. J Neurosci 2009;29:2113-2124
255. Eminli S, Foudi A, Stadtfeld M, Maherali N, Ahfeldt T, Mostoslavsky G etal. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 2009;41:968-976
256. Kim JB, Greber B, Aradzo-Bravo MJ, Meyer J, Park KI, Zaehres H et al. Direct reprogramming of human neural stem cells by OCT4. Nature 2009;461:649-653
257. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33 Suppl:245-254.
258. Hemberger M, Dean W, Reik W. Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington's canal. Nat Rev Mol Cell Biol 2009;10:526-537
259. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008;321:699-702.
260. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008;322:945-949
261. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008;133:250-264
262. Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 2008;18:890-894
263. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature. 2009 Aug 27;460(7259): 1145-1148
264. Tat PA, Sumer H, Jones KL, Upton K, Verma PJ. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells. Cell Transplant. 2010 Feb 8. [Epub ahead of print].
265. Eminli S, Utikal J, Arnold K, Jaenisch R, Hochedlinger K. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 2008;26:2467-2474
266. Li W, Wei W, Zhu S, et al. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 2009;4:16-19
267. Balasubramanian S, Babai N, Chaudhuri A, Qiu F, Bhattacharya S, Dave BJ et al. Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors. Stem Cells 2009;27:3053-3062
268. Liao J, Cui C, Chen S, Ren J, Chen J, Gao Y et al. Generation of Induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell 2009;4:11-15
269. Esteban MA, Xu J, Yang J, Peng M, Qin D, Li W et al. Generation of induced pluripotent stem cell lines from tibetan miniature pig. J Biol Chem 2009;284:17634-17640
270. Wu Z, Chen J, Ren J, Bao L, Liao J, Cui C et al. Generation of Pig Induced Pluripotent Stem Cells with a Drug-Inducible System. J Mol Cell Biol 2009;1:46-54.
271. Aasen T, Raya A, Barrero MJ et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008;26:1276-1284
272. Park I, Arora N, Huo H et al. Disease-specific induced pluripotent stem cells. Cell 2008;134:877-886
273. Lee T, Song S, Kim KL et al. Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circ Res 2010;106:120-128
274. Utikal J, Maherali N, Kulalert W, Hochedlinger K. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 2009;122(Pt 19):3502-3510
275. LohY.AgarwalS, Parkier al. Generation of induced pluripotent stem cells from human blood. Blood 2009; 113:5476-5479
276. Sun N, Panetta NJ, Gupta DM et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 2009;106:15720-15725
277. Xu D, Alipio Z, Fink LM et al. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc Natl Acad Sci USA 2009;106:808-813
278. Zou Z, Zhang Y, Hao L et al. More insight into mesenchymal stem cells and their effects inside the body. Expert Opin Biol Ther 2010;10:215-230
279. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S et al. A Systematic Review of Cellular Transplantation Therapies for Spinal Cord Injury. J Neurotrauma. 2010. Available at: http://www.ncbi.nlm.nih.gov/ pubmed/20146557 [Accessed March 15,2010].
280. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147
281. Meletis K, Frisén J. Blood on the tracks: a simple twist of fate? Trends Neurosci 2003;26:292-296
282. Gu W, Zhang F, Xue Q et al. Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord. Neuropathology. 2009. Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 19845866 [Accessed May 12,2010].
283. Liao W, Xie J, Zhong J et al. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation. 2009;87:350-359
284. Chen J, Zhang ZG, Li Y et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 2003;92:692-699
285. Neuhuber B, Timothy Himes B, Shumsky JS, Gallo G, Fischer I. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 2005;1035:73-85.
286. Taylor L, Jones L, Tuszynski MH, Blesch A. Neurotrophin-3 gradients established by lentiviral gene delivery promote short-distance axonal bridging beyond cellular grafts in the injured spinal cord. J Neurosci 2006;26:9713-9721
287. Lu P, Yang H, Jones LL, Filbin MT, Tuszynski MH. Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci 2004;24:6402-6409
288. Kadoya K, Tsukada S, Lu P et al. Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury. Neuron 2009;64:165-172
289. Bregman BS, Coumans J, Dai HN et al. Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury. Prog Brain Res 2002; 137:257-273
290. Luo J, Zhang H, Jiang X, Xue S, Ke Y. Combination of bone marrow stromal cell transplantation with mobilization by granulocyte-colony stimulating factor promotes functional recovery after spinal cord transection. Acta Neurochir (Wien) 2009; 151:1483-1492
291. Kim KN, Oh SH, Lee KH, Yoon DH. Effect of human mesenchymal stem cell transplantation combined with growth factor infusion in the repair of injured spinal cord. Acta Neurochir Suppl 2006;99:133-136
292. Ohta M, Suzuki Y, Noda T et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol 2004;187:266-278
293. Fan L, DU F, Cheng B, Peng H, Liu S. Migration and distribution of bone marrow stromal cells in injured spinal cord with different transplantation techniques. Chin J Traumatol 2008; 11:94-97
294. Urdzífková' L, Jendelová' P, Glogarová K et al. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma 2006;23:1379-1391
295. Ferriero DM, Miller SP. Imaging selective vulnerability in the developing nervous system. J Anat 2010 Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 20408904 [Accessed May 11,2010].
296. Griffin JW. Basic pathologic processes in the nervous system. Toxicol Pathol 1990;18(lPt2):83-88
297. Guest JD, Hiester ED, Bunge RP. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp Neurol 2005;192:384-393
298. Glazova M, Pak ES, Moretto J et al. Pre-differentiated Embryonic Stem Cells Promote Neuronal Regeneration by Cross-coupling of BDNF and IL-6 Signaling Pathways in the Host Tissue. J. Neurotrauma. 2009. Available at: http://www.ncbi.nlm.nih.gov/ pubmed/19138107 [Accessed May 7, 2010].
299. Bambakidis NC, Miller RH. Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion. Spine J 2004;4:16-26.
300. Lee KH, Yoon DH, ParkYG, Lee BH. Effects of glial transplantation on functional recovery following acute spinal cord injury. J Neurotrauma 2005;22:575-589
301. Teng YD, Lavik EB, Qu X et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA 2002;99:3024-3029
302. Teng YD, Liao W, Choi H et al. Physical activity-mediated functional recovery after spinal cord injury: potential roles of neural stem cells. Regen Med 2006;1:763-776
303. Faulkner JR, Herrmann JE, Woo MJ et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004;24:2143-2155
304. Herrmann JE, Imura T, Song B et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 2008;28:7231-7243
305. Okada S, Nakamura M, Katoh H etal. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 2006;12:829-834
306. Ovanesov MV, Ayhan Y, Wolbert C et al. Astrocytes play a key role in activation of microglia by persistent Boma disease virus infection. J Neuroinflammation 2008;5:50.
307. Lee SC, Liu W, Brosnan CF, Dickson DW. GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia 1994;12:309-318
308. Liu W, Brosnan CF, Dickson DW, Lee SC. Macrophage colony-stimulating factor mediates astrocyte-induced microglial ramification in human fetal central nervous system culture. Am J Pathol 1994;145:48-53.
309. Amankulor NM, Hambardzumyan D, Pyonteck SM et al. Sonic hedgehog pathway activation is induced by acute brain injury and regulated by injury-related inflammation. J Neurosci 2009;29:10299-10308
310. Pifarré P, Prado J, Giralt M et al. Cyclic GMP Phosphodiesterase inhibition alters the Glial Inflammatory Response, Reduces Oxidative Stress and Cell Death and Increases Angiogenesis following Focal Brain Injury. J Neurochem. 2009. Available at: http://www.ncbi.nlm. nih.gov/pubmed/200025 17 [Accessed December 30,2009].
311. Butchi NB, Du M, Peterson KE. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia. Glia. 2009. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19998480 [Accessed December 30,2009].
312. Martin LJ, Pardo CA, Cork LC, Price DL. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol 1994;145:1358-1381
313. Moalem G, Leibowitz-Amit R, Yoles E et al. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 1999;5:49-55.
314. Moalem G, Gdalyahu A, Shani Y et al. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun 2000;15:331-345
315. Chan CCM. Inflammation: beneficial or detrimental after spinal cord injury? Recent Pat CNS Drug Discov 2008;3:189-199
316. Gris P, Tighe A, Levin D, Sharma R, Brown A. Transcriptional regulation of scar gene expression in primary astrocytes. Glia 2007;55:1145-1155
317. Couzin J. Biotechnology. Celebration and concern over U.S. trial of embryonic stem cells. Science 2009;323:568.
318. Kumar AA, Kumar SR, Narayanan R, Arul K, Baskaran M. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. Exp Clin Transplant 2009;7:241-248
319. Geffner LF, Santacruz P, Izurieta M et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant 2008;17:1277-1293
320. Pal R, Venkatararnana NK, Bansal A et al. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy 2009;11:897-911.
321. Syková' E, Homola A, Mazanec R et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006;15:675-687
322. Yoon SH, ShimYS, ParkYH etal. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone /marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 2007;25:2066-2073
323. Moller JC, Klein MA, Haas S et al. Regulation of thrombospondin in the regenerating mouse facial motor nucleus. Glia 1996;17:121-132
324. Qiu J. China Spinal Cord Injury Network: changes from within. Lancet Neurol 2009;8:606-7.
325. SCINet USA. Spinal Cord Injury Clinical Trials Launched in United States. SCINet USA; 2010. Available at: http://www.scinetusa.org/.
326. Gelsinger P, Shamoo AE. Eight years after Jesse's death, are human research subjects any safer? Hastings Cent Rep 2008;38:25-27